CSR Initiatives, Monthly Sales Update, Form 10-K Filing, and Quarterly Results - Research Reports on Apple, Coca-Cola, Ford, Herbalife and General Motors

NEW YORK, November 6, 2014 /PRNewswire/ --

Today, Analysts Review released its research reports regarding Apple Inc. (NASDAQ: AAPL), The Coca-Cola Company (NYSE: KO), Ford Motor Co. (NYSE: F), Herbalife Ltd. (NYSE: HLF) and General Motors Company (NYSE: GM). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7756-100free.

--
Apple Inc. Research Reports
On October 27, 2014, Cupertino-based mobile and personal computer giant Apple Inc. (Apple) reported that it has filed Form 10-K for full-year FY 2014 for the period ended September 27, 2014. The full research reports on Apple are available to download free of charge at:

http://www.analystsreview.com/Nov-06-2014/AAPL/report.pdf

--
The Coca-Cola Company Research Reports
On November 3, 2014, The Coca-Cola Company (Coca-Cola) in association with (RED), a not-for-profit organization which engages businesses and people in the fight against AIDS, has launched a new campaign, titled "Share the Sound of An Aids Free Generation" to support the end of mother-to-child transmission of HIV. As per the Company, the Campaign will feature top artists debuting new music to encourage people to join the efforts for the said cause. The Campaign runs through World AIDS Day on December 1st, 2014 and funds generated will go to Global Fund to fight AIDS, and other severe diseases. Emmanuel Seuge, Vice President, Global Alliances & Ventures, Coca-Cola, said, "One of the primary goals behind the movement of this campaign is to use the power of music to rally millennials in realizing that an AIDS Free generation is within reach." The full research reports on Coca-Cola are available to download free of charge at:

http://www.analystsreview.com/Nov-06-2014/KO/report.pdf

--
Ford Motor Co. Research Reports
On November 3, 2014, Ford Motor Co. (Ford) reported its sales for the month of October 2014. During the month, Ford sold a total of 188,654 vehicles, down 1.7% YoY. According to the Company, Lincoln posted its best October sales results in seven years with total sales of 8,883 vehicles, up 24.6% YoY. Under the Ford brand, the Company sold 22,846 Ford Fusion vehicles, up 5.1 % YoY, marking its 6th consecutive month of record performance. Amongst the Ford Cars, 24,919 escape cars were sold, up 12.0% YoY, reflecting its best ever October performance. Ford Explorer posted record sales since 2004 with sales of 14,455 cars, up 6.4% YoY. In Ford Utilities segment, Ford Transit Connect sold 4,068 utilities, up 28.4% YoY, marking record October performance. The daily rental business on the other hand declined 13%, the decline is a part of a planned reduction for 2014. The full research reports on Ford are available to download free of charge at:

http://www.analystsreview.com/Nov-06-2014/F/report.pdf

--
Herbalife Ltd. Research Reports
On November 3, 2014, Herbalife Ltd. reported its Q3 2014 results. The worldwide net sales were posted as $1.3 billion, up 3.5% YoY. The Company reported adjusted diluted EPS of $1.45 which was lower than estimated $1.51 by analysts at Wall Street. Diluted EPS is projected to range from $1.30 to $1.40 in Q4 2014 and from $5.80 to $5.90 in full-year 2014. The Company also provided guidance for the year 2015, wherein it expects net sales to be in the range of 1.0% decline and 2.0% improvement over 2014. The diluted EPS for 2015 is forecasted to be in the range of $5.45 and $5.75. According to TheStreet, the Company's stock plummeted 11.3% to $49.58 in after-hours trading, following the Company's Q3 2014 earnings miss and a lower than expected Q4 2014 forecast. The full research reports on Herbalife are available to download free of charge at:

http://www.analystsreview.com/Nov-06-2014/HLF/report.pdf

--
General Motors Company Research Reports
On November 3, 2014, General Motors Company (GM) reported sales results for October 2014. In the US, the Company has delivered 226,819 vehicles, marking its best October sales in seven years. The fleets' sales also increased by 6% YoY and the Company reported a 30% profit in commercial sales, driven by small cars, compact crossovers and large pickups. The Chevrolet Cruze brand observed a 51% YoY increase in its deliveries, driving the GM's compact car sales to its highest level since 2003. The Chevrolet Silverado delivered 46,966 units, up 10% YoY, marking its best October since 2007. Kurt McNeil, U.S. Vice President of Sales Operations, said, "We have a strong hand to play, with the industry's newest and most complete line-up of pickups and SUVs, class-leading crossovers like the Buick Encore and a wealth of new products in the pipeline." The full research reports on General Motors are available to download free of charge at:

http://www.analystsreview.com/Nov-06-2014/GM/report.pdf

--
About Analysts Review
We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.


===============
EDITOR'S NOTES:
===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.analystsreview.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.analystsreview.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.analystsreview.com for consideration.

COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Analysts Review